Business & Tech

FTC Warns San Diego Businesses Over COVID-19 Treatment Claims

The FTC warned them to stop making unsubstantiated claims that their products and therapies can treat or prevent COVID-19.

SAN DIEGO, CA — The Federal Trade Commission announced Thursday that it has sent letters to nearly four dozen marketers nationwide, including four based in San Diego, warning them to stop making unsubstantiated claims that their products and therapies can treat or prevent COVID-19.

The FTC identified those sent letters locally as:

-- ActiveHerb Technology, Inc.;
-- Aspire Regenerative Health;
-- EcoShield, LLC; and
-- Forever Ozone.

Find out what's happening in San Diegofor free with the latest updates from Patch.

The letters are among 45 sent nationwide by the Federal Trade Commission in conjunction with its ongoing efforts to protect consumers from COVID-19-related scams, according to the FTC.

Several of the most recent batch of letters target "treatments," including Chinese herbal medications, music therapy, homeopathic treatments and shields claimed to boost the immune system by protecting the wearer from electromagnetic fields, according to the FTC.

Find out what's happening in San Diegofor free with the latest updates from Patch.

A previous round of letters were sent to sellers of vitamins, herbs, colloidal silver, teas, essential oils and other products pitched as scientifically proven coronavirus treatments or preventatives, according to the FTC.

In all, letters have been sent to nearly 100 companies and individuals, according to the commission.


Don't miss local and statewide news about coronavirus developments and precautions. Sign up for Patch news alerts and newsletters.


In the letters, the FTC states that one or more of the efficacy claims made by the marketers are unsubstantiated because they are not supported by scientific evidence, and therefore violate the FTC Act. The letters advise the recipients to immediately stop making all claims that their products can treat or cure COVID-19, and to notify the commission within 48 hours about the specific actions they have taken to address the agency's concerns.